Beijing Balance Medical Technology Co Ltd
Beijing Balance Medical Technology Co.,Ltd. engages in the research and development, production, sale, and service of animal-derived implantable medical devices in China. The company offers artificial biological heart valves, bovine pericardial and porcine aortic valves; pulmonary valved conduit; tissue antigen removal processor, annuloplasty and valvuloplasty rings, and surgical biological patch… Read more
Beijing Balance Medical Technology Co Ltd (688198) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.064x
Based on the latest financial reports, Beijing Balance Medical Technology Co Ltd (688198) has a cash flow conversion efficiency ratio of 0.064x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥70.06 Million) by net assets (CN¥1.10 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Beijing Balance Medical Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Beijing Balance Medical Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Beijing Balance Medical Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Beijing Balance Medical Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
3R Petroleum Óleo e Gás S.A
SA:RRRP3
|
0.166x |
|
Chow Tai Seng Jewellery Co Ltd
SHE:002867
|
0.028x |
|
Nickel Mines Limited
PINK:NICMF
|
0.036x |
|
Global New Material International Holdings Limited
F:69Y
|
N/A |
|
He Bei Cheng De LoLo Co Ltd
SHE:000848
|
0.076x |
|
Sixt SE Pfd.
LSE:0NW8
|
-0.256x |
|
Stagwell Inc
NASDAQ:STGW
|
-0.031x |
|
Guardian Capital Group Ltd. Cl.A Nv (GCG-A.TO
TO:GCG-A
|
0.049x |
Annual Cash Flow Conversion Efficiency for Beijing Balance Medical Technology Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Beijing Balance Medical Technology Co Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.25 Billion | CN¥136.23 Million | 0.109x | -8.28% |
| 2023-12-31 | CN¥1.19 Billion | CN¥141.17 Million | 0.119x | +1.35% |
| 2022-12-31 | CN¥1.10 Billion | CN¥128.85 Million | 0.117x | +51.39% |
| 2021-12-31 | CN¥988.23 Million | CN¥76.49 Million | 0.077x | +27.45% |
| 2020-12-31 | CN¥835.82 Million | CN¥50.76 Million | 0.061x | -27.28% |
| 2019-12-31 | CN¥764.90 Million | CN¥63.88 Million | 0.084x | -69.64% |
| 2018-12-31 | CN¥196.04 Million | CN¥53.92 Million | 0.275x | -20.75% |
| 2017-12-31 | CN¥133.65 Million | CN¥46.38 Million | 0.347x | -27.73% |
| 2016-12-31 | CN¥93.85 Million | CN¥45.07 Million | 0.480x | -- |